Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05273190 · ClinicalTrials.gov registry record · NA
Stimulation of the Larynx to Treat Unexplained Chronic Cough
A NA study of Cough, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05273190: Recruiting NA study of Cough, sponsored by University of Minnesota.
NCT05273190 is a NA study of Cough that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 60 participants, below the 217-participant average among 12 other Cough trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05273190, a NA study of Cough, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Primary Outcome
% of participants indicating agree or strongly agree with statements of usability
Conditions Studied
Interventions
- DEVICE Vibrotactile Stimulation
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-13 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What NCT05273190 shows while recruiting
NCT05273190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 217-participant average among 12 other Cough trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Cough appearing as the primary indexed condition, and to 1 intervention - of which Vibrotactile Stimulation is the first listed.
NCT05273190 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05273190 about?
NCT05273190 is a clinical study titled "Stimulation of the Larynx to Treat Unexplained Chronic Cough". Researchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
What is the current status of trial NCT05273190?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-07-13. Estimated completion is 2027-12-30.
What conditions does trial NCT05273190 study?
This clinical trial studies the following conditions: Cough.
What interventions are being tested in trial NCT05273190?
The interventions under investigation include: Vibrotactile Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05273190?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05273190 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05273190's enrollment target sits among peer trials
60 7th of 12 higher than 6 of 12 other Cough trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cough trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stimulation With Wire Leads to Restore Cough
COMPLETED · NA
-
Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents
COMPLETED · NA
-
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
RECRUITING · Phase 3
-
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
RECRUITING
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
-
Work of Breathing Assessment in Triage Scale
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI